Envarsus® Tablets Administered Once Daily in Combination With Everolimus in Elderly De-novo Kidney Transplant Recipients: Open-label, Multicentre, Single-arm, Pharmacokinetic and Clinical Study
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Chiesi Farmaceutici SpA
- 29 Mar 2017 Planned End Date changed from 1 Feb 2018 to 1 Apr 2018.
- 29 Mar 2017 Status changed from not yet recruiting to recruiting.
- 24 Nov 2016 New trial record